Canada Issues New Treatment Guidelines for Chronic Rhinosinusitis

New Canadian Clinical Practice Guidelines for Acute and Chronic Rhinosinusitis are the first in the world to contain an evidence-based strategy for managing and treating chronic rhinosinusitis (CRS), a disease that is emerging as an area of unmet medical need.  The Guidelines, prepared by leading Canadian multidisciplinary medical experts, are co-published in the Allergy, Asthma & Clinical Immunology (http://www.aacijournal.com/content/7/1/2) and the Journal of Otolaryngology-Head and Neck Surgery.

"Initially considered a chronic bacterial infection, CRS is now recognized as its own clinical entity, and as such, it is no longer reasonable to manage CRS as a prolonged version of ABRS," said Dr. Paul Keith, Department of Medicine, Division of Allergy and Clinical Immunology, McMaster University, Hamilton.  "The need to define specific therapeutic strategies adapted to the pathogenesis was long overdue - the Guidelines now recognize, and set out, more appropriate treatment options and approaches that are required in today's environment."

Read entire PR hereFor over 20 years I've provided successful sinusitis treatments to my patients as they attest in my hundreds of postiive service reviews.  Live in the NYC area, give me a call 866-632-5537.